Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Sales | 13,452,900 | 12,273,900 | 11,448,800 | 10,763,800 | 9,703,300 |
| Cost of Goods | 1,816,300 | 1,630,000 | 1,478,700 | 1,240,400 | 1,171,000 |
| Gross Profit | 11,636,600 | 10,643,900 | 9,970,100 | 9,523,399 | 8,532,300 |
| Operating Expenses | 5,748,300 | 5,298,100 | 4,819,100 | 4,632,800 | 4,559,800 |
| Operating Income | 5,888,600 | 5,345,800 | 5,151,700 | 4,891,000 | 3,972,400 |
| Other Income | 11,000 | -217,000 | -218,700 | -136,200 | -40,900 |
| Pre-tax Income | 5,899,600 | 5,128,800 | 4,933,000 | 4,754,800 | 3,931,500 |
| Income Tax | 1,425,600 | 2,458,700 | 1,237,300 | 1,161,600 | 989,900 |
| Net Income Continuous | 4,474,000 | 2,670,100 | 3,695,700 | 3,593,200 | 2,941,600 |
| Minority Interests | 43,300 | 131,000 | -7,100 | 46,200 | 6,800 |
| Net Income | $4,430,700 | $2,539,100 | $3,702,800 | $3,547,000 | $2,934,800 |
| EPS Basic Total Ops | 21.63 | 11.94 | 16.96 | 15.38 | 12.42 |
| EPS Basic Continuous Ops | 21.84 | 12.56 | 16.92 | 15.58 | 12.44 |
| EPS Diluted Total Ops | 21.58 | 11.92 | 16.93 | 15.34 | 12.37 |
| EPS Diluted Continuous Ops | 21.79 | 12.54 | 16.89 | 15.54 | 12.40 |
| EPS Diluted Before Non-Recurring Items | 26.20 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $6,539,101 | $6,426,801 | $5,834,400 | $5,491,399 | $4,660,600 |